Have a website account?
Log In
or
Register
for exclusive website content.
Subscribe
to TLCR Journal
Title
Full Text
Author
Advanced Search
Home
Journal Info
About
tlcr
Indexing
Editor-in-Chief
Editorial Board
Advisory Committee Board
Editorial Policies
For Authors
Online Submission
Submit Multimedia Files
Author Instruction
Reference Style
Publication Ethics
Conflict of Interest
Human and Animal Rights
Informed Consent
AME Editing Service
For Reviewers
Peer Review Process
Reviewer Instruction
Online Review
Current Issue
Archives
Publish Ahead of Print
Article Processing Charges
Announcements
Home
/
Archives
/
Vol 4, No 1 (February 2015)
Vol 4, No 1 (February 2015): Translational Lung Cancer Research
News
Translational Lung Cancer Research
is indexed by PubMed
Melanie C. He, Grace S. Li
PDF
Pages: 1-4
Full Text
Editorial
Expanding the portfolio of anti-ALK weapons
Luca Mologni
PDF
Pages: 5-7
Full Text
Pre-operative chemotherapy for non-small cell lung carcinoma
Nobuyuki Horita, Tetsukan Woo, Naoki Miyazawa, Takeshi Kaneko
PDF
Pages: 8-14
Full Text
The lesson learned from figitumumab clinical program and the hope for better results in squamous lung cancer
Massimo Di Maio, Giorgio Vittorio Scagliotti
PDF
Pages: 15-17
Full Text
Original Article
Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song
PDF
Pages: 18-26
Full Text
Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice
Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song
PDF
Pages: 27-35
Full Text
Review Article
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Bryan A. Chan, Brett G.M. Hughes
PDF
Pages: 36-54
Full Text
The role of interleukin-6 in malignant mesothelioma
Siti N. Abdul Rahim, Gwo Y. Ho, Jermaine I.G. Coward
PDF
Pages: 55-66
Full Text
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
PDF
Pages: 67-81
Full Text
Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu
PDF
Pages: 82-93
Full Text
Case Report
A 61-year-old man with cough and white sputum
Yanwen Yao, Jie Yin, Xinwu Xiao, Tangfeng Lv, Wenkui Sun, Yong Song
PDF
Pages: 94-98
Full Text
Meet the Professor
Professor Suresh Senan: controversies on radiotherapy in lung cancer
Melanie C. He
PDF
Pages: 99-101
Full Text
Professor Paul Van Schil: close interaction, discussion and cooperation with younger and older colleagues make our profession beautiful and worthwhile
Grace S. Li
PDF
Pages: 102-103
Full Text
Evidence-Based Medicine
CHRNA3 rs1051730 polymorphism and lung cancer susceptibility in Asian population: a meta-analysis
Ping Zhan, Yong Song
PDF
Pages: 104-108
Full Text